COMMODORE CAPITAL LP has filed 6 insider transactions across 2 companies since February 2023.
Most recent transaction: a sale of 1050000 shares of Vera Therapeutics, Inc. ($VERA) on January 10, 2024.
Activity breakdown: 4 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 10, 2024 | Vera Therapeutics, Inc. | $VERA | COMMODORE CAPITAL LP | TenPercentOwner | S | Class A Common Stock | 1050000 | $18.00 | 4,400,000.0000 | 0 | 19.27% | 0.00% |
| June 20, 2023 | Vera Therapeutics, Inc. | $VERA | COMMODORE CAPITAL LP | TenPercentOwner | P | Class A Common Stock | 448217 | $15.17 | 5,450,000.0000 | 0 | 8.96% | 0.00% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | COMMODORE CAPITAL LP | TenPercentOwner | P | Common stock, par value $0.001 per share | 622 | $22.07 | 718,749.0000 | 0 | 0.09% | 0.00% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | COMMODORE CAPITAL LP | TenPercentOwner | J | Common stock, par value $0.001 per share | 729891 | $0.00 | 1,448,640.0000 | 0 | 101.55% | 0.00% |
| Feb. 21, 2023 | Enliven Therapeutics, Inc. | $ELVN | COMMODORE CAPITAL LP | TenPercentOwner | P | Common stock, par value $0.001 per share | 8194 | $5.25 | 2,848,948.0000 | 0 | 0.29% | 0.00% |
| Feb. 22, 2023 | Enliven Therapeutics, Inc. | $ELVN | COMMODORE CAPITAL LP | TenPercentOwner | P | Common stock, par value $0.001 per share | 23565 | $5.11 | 2,872,513.0000 | 0 | 0.83% | 0.00% |